BMGL (Basel Medical Group Ltd Ordinary Shares) Stock Analysis - Hedge Fund Holdings

Basel Medical Group Ltd Ordinary Shares (BMGL) is a publicly traded Healthcare sector company. As of May 21, 2026, BMGL trades at $0.63 with a market cap of $12.39M and a P/E ratio of 0.00. BMGL moved +0.00% today. Year to date, BMGL is +9.49%; over the trailing twelve months it is -67.59%. Its 52-week range spans $0.49 to $9.40. Rallies surfaces BMGL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns BMGL stock?

Rallies tracks hedge fund and 13F ownership for BMGL, including fund holders, share counts, and position changes when data is available.

BMGL Key Metrics

Key financial metrics for BMGL
MetricValue
Price$0.63
Market Cap$12.39M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$9.40
52-Week Low$0.49
Volume2
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest BMGL News

BMGL Analyst Consensus

BMGL analyst coverage data. Average price target: $0.00.

Common questions about BMGL

Who owns BMGL stock?
Rallies tracks hedge fund and 13F ownership for BMGL, including fund holders, share counts, and position changes when data is available.
Does Rallies show 13F holders for BMGL?
Yes. Rallies tracks hedge fund and 13F ownership data for BMGL, including fund names, share counts, latest tracked quarter, and position changes when available.
Is BMGL research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BMGL. It does not provide personalized investment advice.
BMGL

BMGL